Home/Filings/4/0001493152-24-022037
4//SEC Filing

Finley John David 4

Accession 0001493152-24-022037

CIK 0001357459other

Filed

May 29, 8:00 PM ET

Accepted

May 30, 7:44 PM ET

Size

22.4 KB

Accession

0001493152-24-022037

Insider Transaction Report

Form 4
Period: 2024-05-28
Finley John David
DirectorCEO, CFO
Transactions
  • Exercise/Conversion

    Common Stock, par value $0.01

    2024-05-28+3,33512,927 total
  • Tax Payment

    Common Stock, par value $0.01

    2024-05-28$4.76/sh607$2,88913,472 total
  • Exercise/Conversion

    Common Stock, par value $0.01

    2024-05-28+1,62210,059 total
  • Exercise/Conversion

    Common Stock, par value $0.01

    2024-05-28+2,11114,079 total
  • Tax Payment

    Common Stock, par value $0.01

    2024-05-28$4.76/sh467$2,2239,592 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-05-281,6220 total
    Common Stock (1,622 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-05-283,3350 total
    Common Stock (3,335 underlying)
  • Tax Payment

    Common Stock, par value $0.01

    2024-05-28$4.76/sh959$4,56511,968 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-05-282,1110 total
    Common Stock (2,111 underlying)
Holdings
  • Common Stock, par value $0.01

    (indirect: By LLC)
    51
Footnotes (11)
  • [F1]Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023.
  • [F10]This restricted stock unit was granted on June 11, 2023, and all remaining 3,335 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer.
  • [F11]This restricted stock unit was granted on November 21, 2023, and all remaining 2,111 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer.
  • [F2]Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1.
  • [F3]Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023.
  • [F4]Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3.
  • [F5]Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023.
  • [F6]Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 5.
  • [F7]Reporting Person is the managing member of FCW Investments LLC and has the sole investment and voting power over the securities held by this entity.
  • [F8]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
  • [F9]This restricted stock unit was granted on June 8, 2023, and all remaining 1,622 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer.

Documents

1 file

Issuer

PALISADE BIO, INC.

CIK 0001357459

Entity typeother

Related Parties

1
  • filerCIK 0001851034

Filing Metadata

Form type
4
Filed
May 29, 8:00 PM ET
Accepted
May 30, 7:44 PM ET
Size
22.4 KB